The University of Chicago Header Logo

Connection

Robert Rosenfield to Adult

This is a "connection" page, showing publications Robert Rosenfield has written about Adult.
Connection Strength

0.511
  1. The Effect of the Testis on the Ovary: Structure-Function Relationships in a Neonate with a Unilateral Ovotestis (Ovotesticular Disorder of Sex Development)?. Horm Res Paediatr. 2017; 87(3):205-212.
    View in: PubMed
    Score: 0.039
  2. Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood. J Clin Endocrinol Metab. 2015 Apr; 100(4):1537-43.
    View in: PubMed
    Score: 0.034
  3. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum. J Pediatr Adolesc Gynecol. 2015 Dec; 28(6):412-9.
    View in: PubMed
    Score: 0.033
  4. Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril. 2012 Jul; 98(1):242-9.
    View in: PubMed
    Score: 0.028
  5. Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test. Hum Reprod. 2011 Nov; 26(11):3138-46.
    View in: PubMed
    Score: 0.026
  6. Potential diagnostic utility of intermittent administration of short-acting gonadotropin-releasing hormone agonist in gonadotropin deficiency. Fertil Steril. 2010 Dec; 94(7):2697-702.
    View in: PubMed
    Score: 0.024
  7. Characterization of functionally typical and atypical types of polycystic ovary syndrome. J Clin Endocrinol Metab. 2009 May; 94(5):1587-94.
    View in: PubMed
    Score: 0.022
  8. Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population. J Clin Endocrinol Metab. 2009 May; 94(5):1579-86.
    View in: PubMed
    Score: 0.022
  9. Improving balance in regulatory oversight of research in children and adolescents: a clinical investigator's perspective. Ann N Y Acad Sci. 2008; 1135:287-95.
    View in: PubMed
    Score: 0.021
  10. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. J Clin Endocrinol Metab. 2006 Apr; 91(4):1275-83.
    View in: PubMed
    Score: 0.018
  11. A workshop on pubertal hormone replacement options in the United States. J Pediatr Endocrinol Metab. 2006 Jan; 19(1):55-64.
    View in: PubMed
    Score: 0.018
  12. Clinical practice. Hirsutism. N Engl J Med. 2005 Dec 15; 353(24):2578-88.
    View in: PubMed
    Score: 0.018
  13. Expression of 17 beta-hydroxysteroid dehydrogenase type 5 in human ovary: a pilot study. J Soc Gynecol Investig. 2000 Jan-Feb; 7(1):61-4.
    View in: PubMed
    Score: 0.012
  14. A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism. Hum Reprod. 1997 Jul; 12(7):1416-20.
    View in: PubMed
    Score: 0.010
  15. Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor--a clinical research center study. J Clin Endocrinol Metab. 1996 Oct; 81(10):3802-6.
    View in: PubMed
    Score: 0.009
  16. Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center study. J Clin Endocrinol Metab. 1996 Sep; 81(9):3408-11.
    View in: PubMed
    Score: 0.009
  17. Essentials of growth diagnosis. Endocrinol Metab Clin North Am. 1996 Sep; 25(3):743-58.
    View in: PubMed
    Score: 0.009
  18. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1994 Dec; 79(6):1686-92.
    View in: PubMed
    Score: 0.008
  19. Potential of gonadotropin-releasing hormone agonists in the diagnosis of pubertal disorders in girls. Clin Obstet Gynecol. 1993 Sep; 36(3):773-85.
    View in: PubMed
    Score: 0.008
  20. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1993 Feb; 76(2):450-5.
    View in: PubMed
    Score: 0.007
  21. Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid. J Clin Endocrinol Metab. 1992 May; 74(5):1036-9.
    View in: PubMed
    Score: 0.007
  22. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab. 2012 Jul; 97(7):E1342-7.
    View in: PubMed
    Score: 0.007
  23. Clinical review 10: An endocrinologic approach to the patient with hirsutism. J Clin Endocrinol Metab. 1990 Jul; 71(1):1-4.
    View in: PubMed
    Score: 0.006
  24. Use of nafarelin for testing pituitary-ovarian function. J Reprod Med. 1989 Dec; 34(12 Suppl):1044-50.
    View in: PubMed
    Score: 0.006
  25. Lipid cell tumor of the ovary in reference to adult-onset congenital adrenal hyperplasia and polycystic ovary syndrome. A case report. J Reprod Med. 1987 May; 32(5):363-9.
    View in: PubMed
    Score: 0.005
  26. The relationship of mild hirsutism or acne in women to androgens. Arch Dermatol. 1987 Feb; 123(2):209-12.
    View in: PubMed
    Score: 0.005
  27. KAL1 mutations are not a common cause of idiopathic hypogonadotrophic hypogonadism in humans. Mol Hum Reprod. 2007 Mar; 13(3):165-70.
    View in: PubMed
    Score: 0.005
  28. Pilosebaceous physiology in relation to hirsutism and acne. Clin Endocrinol Metab. 1986 May; 15(2):341-62.
    View in: PubMed
    Score: 0.005
  29. The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics. J Clin Endocrinol Metab. 1985 Sep; 61(3):508-13.
    View in: PubMed
    Score: 0.004
  30. Dexamethasone preparation does not alter corticoid and androgen responses to adrenocorticotropin. J Clin Endocrinol Metab. 1985 Mar; 60(3):585-9.
    View in: PubMed
    Score: 0.004
  31. Advances in diagnosis and treatment of short stature, with special reference to the role of growth hormone. J Pediatr. 1984 Jun; 104(6):801-13.
    View in: PubMed
    Score: 0.004
  32. Androgen metabolism by isolated hairs from women with idiopathic hirsutism is usually normal. J Invest Dermatol. 1984 Jan; 82(1):62-6.
    View in: PubMed
    Score: 0.004
  33. Induction of puberty in the hypogonadal girl--practices and attitudes of pediatric endocrinologists in Europe. Horm Res. 2002; 57(1-2):66-71.
    View in: PubMed
    Score: 0.003
  34. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001 Dec; 86(12):5925-33.
    View in: PubMed
    Score: 0.003
  35. Effect of follicle-stimulating hormone on ovarian androgen production in a woman with isolated follicle-stimulating hormone deficiency. N Engl J Med. 2000 Oct 19; 343(16):1197-8.
    View in: PubMed
    Score: 0.003
  36. Gonadotropin-releasing hormone infusion test in the distinction of hypopituitary patients from normal subjects. Fertil Steril. 1979 May; 31(5):507-12.
    View in: PubMed
    Score: 0.003
  37. Plasma free androgen patterns in hirsute women and their diagnostic implications. Am J Med. 1979 Mar; 66(3):417-21.
    View in: PubMed
    Score: 0.003
  38. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999 Jan; 22(1):141-6.
    View in: PubMed
    Score: 0.003
  39. Direct inhibition of Leydig cell function by estradiol. J Clin Endocrinol Metab. 1978 Dec; 47(6):1368-73.
    View in: PubMed
    Score: 0.003
  40. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997 Jul; 82(7):2108-16.
    View in: PubMed
    Score: 0.002
  41. The relationship between plasma testosterone and mean LH levels in men. J Clin Endocrinol Metab. 1977 Jul; 45(1):30-4.
    View in: PubMed
    Score: 0.002
  42. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997 Feb; 82(2):524-30.
    View in: PubMed
    Score: 0.002
  43. The effects of fluoxymesterone administration on testicular function. J Clin Endocrinol Metab. 1977 Jan; 44(1):121-9.
    View in: PubMed
    Score: 0.002
  44. Obesity and oligomenorrhea are associated with hyperandrogenism independent of hirsutism. J Clin Endocrinol Metab. 1976 Apr; 42(4):765-9.
    View in: PubMed
    Score: 0.002
  45. Plasma unbound and unconjugated androgens in oriental men. J Endocrinol. 1976 Jan; 68(1):165-6.
    View in: PubMed
    Score: 0.002
  46. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest. 1995 Jul; 96(1):520-7.
    View in: PubMed
    Score: 0.002
  47. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab. 1994 Nov; 79(5):1328-33.
    View in: PubMed
    Score: 0.002
  48. Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1993 May; 76(5):1241-7.
    View in: PubMed
    Score: 0.002
  49. Maturation of gonadotropin and sex steroid responses to gonadotropin-releasing hormone agonist in males. J Clin Endocrinol Metab. 1993 Feb; 76(2):362-6.
    View in: PubMed
    Score: 0.002
  50. Androstenediol levels in human peripheral plasma. J Clin Endocrinol Metab. 1972 Dec; 35(6):818-22.
    View in: PubMed
    Score: 0.002
  51. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992 Jul 16; 327(3):157-62.
    View in: PubMed
    Score: 0.002
  52. Managing delayed puberty. Postgrad Med. 1972 May; 51(5):204-9.
    View in: PubMed
    Score: 0.002
  53. Adrenal and ovarian contributions to the elevated free plasma androgen levels in hirsute women. J Clin Endocrinol Metab. 1972 Jan; 34(1):92-8.
    View in: PubMed
    Score: 0.002
  54. Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics. Mol Endocrinol. 1991 Oct; 5(10):1562-9.
    View in: PubMed
    Score: 0.002
  55. Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects. J Clin Endocrinol Metab. 1971 Jun; 32(6):717-28.
    View in: PubMed
    Score: 0.002
  56. Androgens and androgen responsiveness in the feminizing testis syndrome. Comparison of complete and "incomplete" forms. J Clin Endocrinol Metab. 1971 May; 32(5):625-32.
    View in: PubMed
    Score: 0.002
  57. A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies. J Clin Endocrinol Metab. 1989 Nov; 69(5):963-7.
    View in: PubMed
    Score: 0.001
  58. A competitive protein binding method for the measurement of plasma androstenedione. Steroids. 1969 Sep; 14(3):251-61.
    View in: PubMed
    Score: 0.001
  59. Measurement of plasma testosterone by means of competitive protein binding analysis. J Clin Endocrinol Metab. 1969 Jun; 29(6):854-9.
    View in: PubMed
    Score: 0.001
  60. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989 Mar 02; 320(9):559-65.
    View in: PubMed
    Score: 0.001
  61. Recovery from glucocorticoid inhibition of the responses to corticotrophin-releasing hormone. Clin Endocrinol (Oxf). 1988 May; 28(5):471-7.
    View in: PubMed
    Score: 0.001
  62. Sex hormone-binding globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: the value of changes after short term triiodothyronine administration. J Clin Endocrinol Metab. 1988 Apr; 66(4):740-6.
    View in: PubMed
    Score: 0.001
  63. Studies of androgen metabolism and action in cultured hair and skin cells. J Steroid Biochem. 1986 May; 24(5):1053-60.
    View in: PubMed
    Score: 0.001
  64. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab. 1986 May; 62(5):840-8.
    View in: PubMed
    Score: 0.001
  65. Plasma androgens in women with acne vulgaris. J Invest Dermatol. 1983 Jul; 81(1):70-4.
    View in: PubMed
    Score: 0.001
  66. Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women. J Clin Endocrinol Metab. 1982 Aug; 55(2):251-7.
    View in: PubMed
    Score: 0.001
  67. Bioactive luteinizing hormone pituitary reserves during normal and abnormal male puberty. J Clin Endocrinol Metab. 1982 Jul; 55(1):140-6.
    View in: PubMed
    Score: 0.001
  68. Adrenarche: changing adrenal response to adrenocorticotropin. J Clin Endocrinol Metab. 1981 Jun; 52(6):1129-36.
    View in: PubMed
    Score: 0.001
  69. Estradiol-testosterone binding interactions and free plasma estradiol under physiological conditions. J Clin Endocrinol Metab. 1981 May; 52(5):868-74.
    View in: PubMed
    Score: 0.001
  70. Ovarian hyperandrogenism with normal and abnormal histologic findings of the ovaries. Am J Obstet Gynecol. 1979 Jun 15; 134(4):445-52.
    View in: PubMed
    Score: 0.001
  71. Partial gonadotrophin-resistance in pseudohypoparathyroidism. Acta Endocrinol (Copenh). 1978 Jun; 88(2):321-8.
    View in: PubMed
    Score: 0.001
  72. Endocrine and metabolic studies in a patient with male pseudohermaphroditism and true agonadism. Am J Obstet Gynecol. 1977 Aug 15; 128(8):862-7.
    View in: PubMed
    Score: 0.001
  73. The effects of dexamethasone on plasma free androgens during the normal menstrual cycle. Am J Obstet Gynecol. 1976 Dec 15; 126(8):982-6.
    View in: PubMed
    Score: 0.001
  74. Endocrinologic characteristics of partial ovarian failure. J Clin Endocrinol Metab. 1976 Aug; 43(2):449-52.
    View in: PubMed
    Score: 0.001
  75. The levodopa test of growth hormone reserve in children. Am J Dis Child. 1973 Nov; 126(5):589-92.
    View in: PubMed
    Score: 0.000
  76. Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity. N Engl J Med. 1973 May 31; 288(22):1144-8.
    View in: PubMed
    Score: 0.000
  77. Sequential changes in total and free testosterone and androstenedione in plasma during spontaneous and Clomid-induced ovulatory cycles. Am J Obstet Gynecol. 1973 Feb 15; 115(4):478-83.
    View in: PubMed
    Score: 0.000
  78. The plasma growth hormone response to insulin-induced hypoglycemia in children with retardation of growth. Pediatrics. 1967 Jun; 39(6):844-52.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.